IPP Bureau

UFlex introduces a range of innovative and sustainable packaging solutions
UFlex introduces a range of innovative and sustainable packaging solutions

By IPP Bureau - February 15, 2022

Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021

India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
India’s tech-enabled vaccination drive applauded at India-Africa Health Summit

By IPP Bureau - February 15, 2022

It will open new frontier for south-to-south collaboration and innovation transfer

PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients
PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients

By IPP Bureau - February 15, 2022

The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country

Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations
Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations

By IPP Bureau - February 15, 2022

She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry

Visionflex chooses Vonage for its next-gen remote healthcare and diagnostic services
Visionflex chooses Vonage for its next-gen remote healthcare and diagnostic services

By IPP Bureau - February 14, 2022

Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

By IPP Bureau - February 14, 2022

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data

WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19
WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19

By IPP Bureau - February 14, 2022

The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification

Zydus gets 180 days of shared exclusivity for Roflumilast tablets
Zydus gets 180 days of shared exclusivity for Roflumilast tablets

By IPP Bureau - February 14, 2022

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad

Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

By IPP Bureau - February 14, 2022

Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered

Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit
Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit

By IPP Bureau - February 14, 2022

The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes

Glenmark to commercialize AstraZeneca’s asthma drug in Columbia
Glenmark to commercialize AstraZeneca’s asthma drug in Columbia

By IPP Bureau - February 14, 2022

AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia

Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct

By IPP Bureau - February 14, 2022

Key takeaways of recent quarter & conference call highlights

First procedure in India performed with Medtronic's Intellis spinal cord stimulator
First procedure in India performed with Medtronic's Intellis spinal cord stimulator

By IPP Bureau - February 14, 2022

The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator

Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane
Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane

By IPP Bureau - February 14, 2022

Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific

Avantor breaks ground on new distribution center to serve biopharmaceutical industry in Ireland
Avantor breaks ground on new distribution center to serve biopharmaceutical industry in Ireland

By IPP Bureau - February 14, 2022

Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry

Latest Stories

Interviews

Packaging